VITA 34 AG (V3V.DE)
EUR 4.28
(2.88%)
EUR 4.28
(2.88%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 77.06 Million EUR | 11.78% |
| 2022 | 68.94 Million EUR | 142.59% |
| 2021 | 28.41 Million EUR | 41.59% |
| 2020 | 20.07 Million EUR | -0.87% |
| 2019 | 20.24 Million EUR | -0.8% |
| 2018 | 20.41 Million EUR | 6.38% |
| 2017 | 19.18 Million EUR | 17.78% |
| 2016 | 16.29 Million EUR | 14.97% |
| 2015 | 14.16 Million EUR | 2.78% |
| 2014 | 13.78 Million EUR | 1.71% |
| 2013 | 13.55 Million EUR | -0.36% |
| 2012 | 13.6 Million EUR | -14.99% |
| 2011 | 16 Million EUR | -5.67% |
| 2010 | 16.96 Million EUR | 12.36% |
| 2009 | 15.09 Million EUR | 0.94% |
| 2008 | 14.95 Million EUR | -3.04% |
| 2007 | 15.42 Million EUR | 0.0% |
| 2006 | - EUR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 19.47 Million EUR | 4.94% |
| 2024 Q1 | 18.55 Million EUR | -8.95% |
| 2023 Q3 | 20.41 Million EUR | 11.15% |
| 2023 Q4 | 20.38 Million EUR | -0.16% |
| 2023 Q1 | 17.9 Million EUR | -1.5% |
| 2023 FY | 77.06 Million EUR | 11.78% |
| 2023 Q2 | 18.36 Million EUR | 2.57% |
| 2022 Q2 | 16.62 Million EUR | 7.42% |
| 2022 FY | 68.94 Million EUR | 142.59% |
| 2022 Q3 | 18.65 Million EUR | 12.18% |
| 2022 Q4 | 18.17 Million EUR | -2.57% |
| 2022 Q1 | 15.48 Million EUR | 31.5% |
| 2021 Q2 | 5.44 Million EUR | 1.19% |
| 2021 Q4 | 11.77 Million EUR | 102.13% |
| 2021 Q3 | 5.82 Million EUR | 7.0% |
| 2021 FY | 28.41 Million EUR | 41.59% |
| 2021 Q1 | 5.37 Million EUR | 6.6% |
| 2020 Q1 | 4.67 Million EUR | -8.85% |
| 2020 Q4 | 5.04 Million EUR | -6.97% |
| 2020 Q2 | 4.92 Million EUR | 5.41% |
| 2020 FY | 20.07 Million EUR | -0.87% |
| 2020 Q3 | 5.42 Million EUR | 10.09% |
| 2019 Q1 | 4.78 Million EUR | -1.52% |
| 2019 FY | 20.24 Million EUR | -0.8% |
| 2019 Q2 | 4.98 Million EUR | 4.14% |
| 2019 Q3 | 5.35 Million EUR | 7.39% |
| 2019 Q4 | 5.12 Million EUR | -4.17% |
| 2018 Q2 | 5.1 Million EUR | 0.47% |
| 2018 Q3 | 5.37 Million EUR | 5.39% |
| 2018 Q4 | 4.85 Million EUR | -9.6% |
| 2018 FY | 20.41 Million EUR | 6.38% |
| 2018 Q1 | 5.07 Million EUR | -6.64% |
| 2017 Q3 | 5.59 Million EUR | 37.48% |
| 2017 Q1 | 4.08 Million EUR | -4.11% |
| 2017 FY | 19.18 Million EUR | 17.78% |
| 2017 Q4 | 5.43 Million EUR | -2.86% |
| 2017 Q2 | 4.07 Million EUR | -0.25% |
| 2016 FY | 16.29 Million EUR | 14.97% |
| 2016 Q3 | 4.01 Million EUR | -4.68% |
| 2016 Q4 | 4.25 Million EUR | 6.06% |
| 2016 Q2 | 4.21 Million EUR | 10.47% |
| 2016 Q1 | 3.81 Million EUR | -1.68% |
| 2015 Q4 | 3.87 Million EUR | 0.03% |
| 2015 Q3 | 3.87 Million EUR | 15.71% |
| 2015 Q1 | 3.06 Million EUR | -17.28% |
| 2015 FY | 14.16 Million EUR | 2.78% |
| 2015 Q2 | 3.34 Million EUR | 9.12% |
| 2014 Q1 | 3.21 Million EUR | -11.85% |
| 2014 Q2 | 2.87 Million EUR | -10.46% |
| 2014 Q3 | 3.98 Million EUR | 38.55% |
| 2014 Q4 | 3.71 Million EUR | -6.92% |
| 2014 FY | 13.78 Million EUR | 1.71% |
| 2013 Q4 | 3.64 Million EUR | 6.99% |
| 2013 Q3 | 3.4 Million EUR | 2.25% |
| 2013 Q2 | 3.33 Million EUR | 5.11% |
| 2013 Q1 | 3.17 Million EUR | -9.32% |
| 2013 FY | 13.55 Million EUR | -0.36% |
| 2012 Q2 | 3.47 Million EUR | 10.48% |
| 2012 FY | 13.6 Million EUR | -14.99% |
| 2012 Q3 | 3.48 Million EUR | 0.09% |
| 2012 Q4 | 3.49 Million EUR | 0.43% |
| 2012 Q1 | 3.14 Million EUR | -19.26% |
| 2011 Q2 | 4.05 Million EUR | 9.26% |
| 2011 Q3 | 4.33 Million EUR | 6.7% |
| 2011 FY | 16 Million EUR | -5.67% |
| 2011 Q4 | 3.89 Million EUR | -9.95% |
| 2011 Q1 | 3.71 Million EUR | -25.84% |
| 2010 Q2 | 4.1 Million EUR | 17.7% |
| 2010 Q1 | 3.49 Million EUR | -12.64% |
| 2010 FY | 16.96 Million EUR | 12.36% |
| 2010 Q4 | 5 Million EUR | 14.99% |
| 2010 Q3 | 4.35 Million EUR | 5.99% |
| 2009 Q1 | 3.4 Million EUR | 0.0% |
| 2009 Q3 | 4.07 Million EUR | 12.5% |
| 2009 FY | 15.09 Million EUR | 0.94% |
| 2009 Q4 | 3.99 Million EUR | -1.96% |
| 2009 Q2 | 3.62 Million EUR | 6.5% |
| 2008 Q2 | 3.6 Million EUR | 0.0% |
| 2008 FY | 14.95 Million EUR | -3.04% |
| 2007 FY | 15.42 Million EUR | 0.0% |
| 2006 FY | - EUR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Fresenius Medical Care AG & Co. KGaA | 19.45 Billion EUR | 99.604% |
| Fresenius SE & Co. KGaA | 22.29 Billion EUR | 99.654% |
| LIMES Schlosskliniken AG | 37.17 Million EUR | -107.306% |
| M1 Kliniken AG | 316.31 Million EUR | 75.638% |
| Maternus-Kliniken Aktiengesellschaft | 102.3 Million EUR | 24.675% |
| MEDICLIN Aktiengesellschaft | 761.59 Million EUR | 89.882% |
| RHÖN-KLINIKUM Aktiengesellschaft | 1.73 Billion EUR | 95.558% |